Review: taking Azor and Acetaminophen together


Summary

Drug interactions are reported among people who take Azor and Acetaminophen together. This review analyzes the effectiveness and drug interactions between Azor and Acetaminophen. It is created by eHealthMe based on reports of 46 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Azor and Acetaminophen >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Azor

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. (latest outcomes from Azor 1,201 users)

Acetaminophen

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. (latest outcomes from Acetaminophen 72,922 users)

On Aug, 19, 2016

46 people who take Azor, Acetaminophen are studied.


Number of reports submitted per year:

Azor and Acetaminophen drug interactions.

Drug effectiveness over time:

Azor:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Acetaminophen:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Azor:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Acetaminophen:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Azor:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Acetaminophen:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • death
  • hepatitis cholestatic
  • second primary malignancy
  • brain neoplasm
1 - 6 months:
  • bradycardia
  • brain neoplasm
  • death
  • second primary malignancy
6 - 12 months:
  • brain neoplasm
  • death
  • second primary malignancy
  • blood glucose increased
1 - 2 years:
  • blood glucose increased
not specified:
  • dizziness
  • diarrhoea
  • musculoskeletal pain
  • arthralgia
  • cataract
  • dyspnoea
  • myalgia
  • cholelithiasis
  • dehydration
  • bone pain

Most common drug interactions by gender *:

female:
  • diarrhoea
  • dizziness
  • fatigue
  • renal failure
  • abdominal discomfort
  • alopecia
  • anxiety
  • blood glucose increased
  • cataract
  • depression
male:
  • musculoskeletal pain
  • brain neoplasm
  • death
  • second primary malignancy
  • arthralgia
  • bone pain
  • dizziness
  • lung carcinoma cell type unspecified stage i
  • malaise
  • myalgia

Most common drug interactions by age *:

30-39:
  • abdominal pain
  • pancreatitis
40-49:
  • asthenia
  • atrioventricular block first degree
  • blood glucose increased
  • blood triglycerides increased
  • chest discomfort
  • chest pain
  • diabetes mellitus
  • dyspnoea
  • fatigue
  • fibrin d dimer increased
50-59:
  • cholecystitis
  • gallbladder disorder
  • hepatitis cholestatic
  • infection
  • localised infection
  • carbon dioxide decreased
  • cholangitis
  • cholelithiasis
  • dehydration
  • anaemia
60+:
  • dizziness
  • diarrhoea
  • musculoskeletal pain
  • arthralgia
  • myalgia
  • brain neoplasm
  • death
  • second primary malignancy
  • bone pain
  • cataract

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Azor and Acetaminophen?

Can you answer these questions?

More questions for: Azor, Acetaminophen

You may be interested in these reviews

More reviews for: Azor, Acetaminophen

On eHealthMe, Azor (amlodipine besylate; olmesartan medoxomil) is often used to treat high blood pressure. Acetaminophen (acetaminophen) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.